General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Changes in Stockholders' Deficit

v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Sep. 30, 2021 $ 1,186 $ 48,770,059 $ (49,796,919) $ (1,025,674)
Balance, shares at Sep. 30, 2021 1,186,901      
Net loss (5,275,854) (5,275,854)
Issuance of common stock and warrants, net of financing costs $ 64 1,609,077 1,609,141
Issuance of common stock and warrants, net of financing costs, shares 63,833      
Stock-based compensation expense 499,584 499,584
Vesting of restricted stock $ 2 (2)
Vesting of restricted stock, shares 2,000      
Balance at Sep. 30, 2022 $ 1,252 50,878,718 (55,072,773) (4,192,803)
Balance, shares at Sep. 30, 2022 1,252,734      
Net loss (1,800,056) (1,800,056)
Stock-based compensation expense 104,026 104,026
Balance at Dec. 31, 2022 $ 1,252 50,982,744 (56,872,829) (5,888,833)
Balance, shares at Dec. 31, 2022 1,252,734      
Balance at Sep. 30, 2022 $ 1,252 50,878,718 (55,072,773) (4,192,803)
Balance, shares at Sep. 30, 2022 1,252,734      
Net loss         (2,702,533)
Balance at Mar. 31, 2023 $ 1,275 51,387,943 (57,775,306) (6,386,088)
Balance, shares at Mar. 31, 2023 1,274,601      
Balance at Sep. 30, 2022 $ 1,252 50,878,718 (55,072,773) (4,192,803)
Balance, shares at Sep. 30, 2022 1,252,734      
Net loss (6,982,836) (6,982,836)
Issuance of common stock and warrants, net of financing costs $ 3,345 2,206,495 2,209,840
Issuance of common stock and warrants, net of financing costs, shares 3,344,321      
Issuance of common stock upon conversion of convertible notes $ 60 718,858 718,918
Issuance of common stock upon conversion of convertible notes, shares 59,912      
Issuance of common stock and warrants with convertible notes $ 20 440,297 440,317
Issuance of common stock and warrants with convertible notes, shares   20,210      
Exchange of warrants into common stock $ 12 49,265   49,277
Exchange of warrants into common stock, shares   12,019      
Stock-based compensation expense 249,555 249,555
Stock-based compensation expense, shares   250      
Balance at Sep. 30, 2023 $ 4,689 54,543,188 (62,055,609) (7,507,732)
Balance, shares at Sep. 30, 2023 4,689,446      
Balance at Dec. 31, 2022 $ 1,252 50,982,744 (56,872,829) (5,888,833)
Balance, shares at Dec. 31, 2022 1,252,734      
Net loss (902,477) (902,477)
Issuance of common stock and warrants, net of financing costs $ 10 287,410 287,420
Issuance of common stock and warrants, net of financing costs, shares 9,598      
Exchange of warrants into common stock $ 13 49,265 49,278
Exchange of warrants into common stock, shares   12,019      
Stock-based compensation expense 68,524 68,524
Vesting of restricted stock
Vesting of restricted stock, shares   250      
Balance at Mar. 31, 2023 $ 1,275 51,387,943 (57,775,306) (6,386,088)
Balance, shares at Mar. 31, 2023 1,274,601      
Balance at Sep. 30, 2023 $ 4,689 54,543,188 (62,055,609) (7,507,732)
Balance, shares at Sep. 30, 2023 4,689,446      
Net loss (2,681,652) (2,681,652)
Issuance of common stock upon conversion of convertible notes $ 53 587,906 587,959
Issuance of common stock upon conversion of convertible notes, shares 52,918      
Stock-based compensation expense 25,909 25,909
Balance at Dec. 31, 2023 $ 4,742 55,157,003 (64,737,261) (9,575,516)
Balance, shares at Dec. 31, 2023 4,742,364      
Balance at Sep. 30, 2023 $ 4,689 54,543,188 (62,055,609) (7,507,732)
Balance, shares at Sep. 30, 2023 4,689,446      
Net loss         (4,150,791)
Balance at Mar. 31, 2024 $ 4,444 55,324,472 (66,206,400) (10,877,484)
Balance, shares at Mar. 31, 2024 4,444,364      
Balance at Dec. 31, 2023 $ 4,742 55,157,003 (64,737,261) (9,575,516)
Balance, shares at Dec. 31, 2023 4,742,364      
Net loss (1,469,139) (1,469,139)
Issuance of common stock and warrants, net of financing costs 148,891 148,891
Issuance of common stock and warrants, net of financing costs, shares        
Issuance of common stock upon conversion of convertible notes $ 2 18,278 18,280
Issuance of common stock upon conversion of convertible notes, shares 2,000      
Exchange of warrants into common stock $ (300) 300
Exchange of warrants into common stock, shares   (300,000)      
Balance at Mar. 31, 2024 $ 4,444 $ 55,324,472 $ (66,206,400) $ (10,877,484)
Balance, shares at Mar. 31, 2024 4,444,364